Feedback / Questions
adriforant (ZPL 3893787) - Novartis
ZPL389: Initiation of P2 trial in atopic dermatitis in 2018
(Novartis)
-
Nov 14, 2017 -
R&D Update
New P2 trial
•
Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Inflammation
https://www.novartis.com/sites/www.novartis.com/files/2017-11-r-d-day-investor-presentation.pdf
Nov 14, 2017
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious